A Structured Training Framework Aims to Standardize Brachytherapy Practice in Soft Tissue Sarcoma

Brachytherapy for soft tissue sarcoma (STS) can achieve local control rates of 75% to 100%, but inconsistent training and limited case exposure have left many radiation oncologists, especially residents, underprepared to deliver it safely and confidently.¹ A new technical review offers a competency-aligned, step-by-step framework designed to close that gap covering treatment planning, delivery, toxicity management, and quality assurance from the ground up.

The Problem: Training Gaps in a High-Stakes Skill

A 2019 survey of US radiation oncology residents found that while 96% of senior trainees believed learning brachytherapy was important, caseload was cited as the greatest barrier to achieving confidence and comfort levels varied significantly by disease site.² STS brachytherapy is especially complex, requiring proficiency not just in radiation physics, but also in surgical anatomy, catheter implantation, wound management, and coordinated multidisciplinary care. The American Brachytherapy Society (ABS) and Groupe Européen de Curiethérapie of the European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) have previously published consensus guidelines outlining training competencies, but translating those into a practical workflow for learners has remained a missing piece.

How the Framework Was Built

This technical review operationalizes the ABS/GEC-ESTRO framework specifically for STS interstitial brachytherapy. The authors walk through each major competency domain, including clinical indications, implant geometry principles, CT-based simulation, target and organ-at-risk delineation, dose prescription and fractionation, treatment planning system operation, plan evaluation, delivery considerations, toxicity management, and quality assurance. The review is organized to mirror the actual workflow a trainee would encounter in clinical practice.

Indications and Geometry Come First

The paper clarifies that brachytherapy is appropriate as monotherapy for intermediate- or high-grade tumors under 10 cm, or as a boost combined with external beam radiation therapy (EBRT) for larger or higher-risk lesions. Implant geometry is emphasized as the foundation of a good plan: catheters should be spaced 1 to 1.5 cm apart in parallel alignment and extend at least 2 cm beyond the tumor bed. The authors note that "geometric optimization and dwell-time optimization are complementary processes, with geometric quality serving as the foundation upon which manual or inverse optimization algorithms achieve a safe and effective dose distribution."

CT-Based Planning Is the Standard of Care

The review describes how CT simulation (2 to 3 mm slices), catheter digitization, and fusion with preoperative MRI allow accurate target delineation and dose-volume histogram analysis. There is no current role for MRI simulation, ultrasound, or PET/CT in this setting.

Dose and Fractionation Options and Wound Management 

For high-dose-rate monotherapy, 36 Gy in 10 twice-daily fractions is among the most commonly used regimens. For combined EBRT and brachytherapy boost, 12 to 20 Gy in twice-daily fractions is typical.

Wound-healing complications are the most common acute toxicity. Delayed reconstruction, use of negative-pressure wound therapy, and timing of source loading (typically at least 5 days postoperatively for primary closure) are each described with practical rationale. Late effects including fibrosis, neuropathy, fracture, and edema are mapped to their risk factors and mitigation strategies.

The review also details pretreatment source verification, catheter patency checks, independent parameter validation, and incident response protocols. It emphasizes a culture of transparent reporting and structured review of near misses.

Why This Matters

The clinical rationale for brachytherapy in STS is strong, and combined modality treatment achieves local control rates of 85% to 100% in appropriately selected patients. Yet the technique remains underutilized, in part because structured training pathways are scarce and inconsistent across programs.

By organizing established evidence and practical techniques into a coherent, trainee-centered document, this paper addresses a real clinical need. Institutions can adapt the framework to their own resources and case mix without sacrificing core safety principles.

As brachytherapy technology evolves, including inverse planning tools and expanding intraoperative radiation therapy capabilities, training frameworks will need regular updating, and the authors call for ongoing refinement as experience grows. Simulation-based training, structured mentorship, and formal case-volume tracking may all play a role in helping residency programs meet the competency standards outlined here.

References

1. Friedes C, Rishi A, Saini A, et al. Training-oriented framework for brachytherapy treatment planning in soft tissue sarcoma. Brachytherapy. Published online May 13, 2026. doi:10.1016/j.brachy.2026.04.006
2. Marcrom SR, Kahn JM, Colbert LE, et al. Brachytherapy training survey of radiation oncology residents. Int J Radiat Oncol Biol Phys. 2019;103(3):557-560. doi:10.1016/j.ijrobp.2018.10.023